Respiratory infections can increase the risk of cardiovascular diseases among all people. Studies show that for CVD patients diagnosed with flu, the risk of experiencing a heart attack increases 6-fold.

Tremendously exciting times and possibly underestimating the enormity of its impact. These are some of the comments we hear when experts share their insights on the recently available RSV vaccines.

This report covers the period from August 2023 to August 2024, highlighting the latest developments within the vaccine industry and how these innovations are addressing existing and upcoming health threats.

Some children and young people (CYP) infected with SARS-COV-2 experience impairing symptoms post-infection, known as post-COVID-19 condition (PCC).

In conclusions recently approved, the Council puts forward a series of measures aimed at improving cardiovascular health in the EU, focusing specifically on prevention, early detection, treatment and rehabilitation.

The new RSV vaccines are medical milestones. But what is owed to the families who unknowingly helped pave the way?

From being a largely unknown pathogen, RSV is now almost a household word. New solutions, such as long-acting monoclonal antibodies and maternal vaccination, both recently recommended by WHO, could dramatically alter the RSV landscape.

This Review provides an overview of RSV vaccines highlighting different target populations, antigens, and trial results. As RSV vaccines have not yet reached low-income and middle-income countries, next steps are outlined to minimise the delay.

ECDC’s annual conference took place from 20-22 November in Stockholm, bringing together hundreds of public health professionals—from epidemiologists to veterinarians, microbiologists, clinicians, and more.

In this phenomenal episode, three leading experts in the field of vaccinology and immunology dive into the science behind various vaccine platforms and immune responses

Influenza vaccine effectiveness (VE) is commonly assessed against prevention of illness that requires medical attention. Few studies have evaluated VE against secondary influenza infections.

IDC launched a social media campaign to highlight the impact of influenza on people living with diabetes and the crucial importance of influenza vaccine uptake for this risk group.